One essential step forward in endoscopic care.
EXALT™ Model D Single-Use Duodenoscope
Raise the standard of care with EXALT Model D, the world’s first single-use duodenoscope. Designed to provide the same high performance you expect from a reusable scope in a groundbreaking single-use platform, EXALT Model D eliminates infection risk due to cross-contamination from ineffective reprocessing while also reducing associated operational costs for endoscopic retrograde cholangiopancreatography (ERCP) procedures.
Get Medicare reimbursement
No reprocessing required
Installation & support
Review the data from peer-reviewed, published data and hear what leading physicians have to say about the results.
Meeting the needs of ASGE complexity grades
See how the EXALT Model D Single-Use Duodenoscope delivers robust stability, maneuverability and control in ERCP procedures. Model D was studied in three published peer-reviewed in-human clinical trials with 168 patients from these trials, across all ERCP complexity grades,* resulting in a 95.8% success rate with a single-use duodenoscope. In two of the trials, patients were consecutively enrolled allowing for a wide range of challenging ERCPs.*As defined by the American Society for Gastrointestinal Endoscopy
An economically viable solution
Learn how EXALT Model D provides an economically viable alternative to reusable duodenoscopes and what Medicare’s Transitional Pass-through Payment means for your facility.
Built for performance
EXALT Model D offers the performance, control and maneuverability you need in a single-use platform.
Prevent patient infection
EXALT Model D eliminates patient-to-patient infection risk due to ineffective duodenoscope reprocessing.
Our team makes it easy to install and integrate EXALT Model D into your facility and your practice.
Stay up to date
Sign up to receive periodic emails about EXALT Model D case studies, clinical data, reimbursement and more.
Connect with a rep
Request a rep to learn how EXALT Model D may help you address infection risks and improve patients’ lives.